Back to trial details

Intake questionnaire

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Applying to Froedtert & MCW Cancer Center · Milwaukee, Wisconsin

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Breast Cancer?
3. Are you able to travel to Milwaukee for study visits?